ISSN 2472-0429

Advances in Cancer Prevention
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • Adv Cancer Prev,

Clinical Efficacy of Antibodies in Cancer Patients

Vipin Thampi*
Department of Health Promotion, Researcher at Indian Cancer Society, Kollam, Kerala, India
*Corresponding Author : Vipin Thampi, Department of Health Promotion, Researcher at Indian Cancer Society, Kollam, Kerala, India, Email: vipin_thampi@macc-fm.com

Received Date: Feb 28, 2023 / Published Date: Mar 28, 2023

Abstract

Antibody-based therapy for cancer has become established over the past 15 years and is now one of the most successful and important strategies for treating patients with haematological malignancies and solid tumours.

Citation: Thampi V (2023) Clinical Efficacy of Antibodies in Cancer Patients. AdvCancer Prev 7: 158.

Copyright: © 2023 Thampi V. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Post Your Comment Citation
Share This Article
Recommended Conferences
Article Usage
  • Total views: 452
  • [From(publication date): 0-2023 - Nov 06, 2024]
  • Breakdown by view type
  • HTML page views: 386
  • PDF downloads: 66
Top